SS Innovations raises $18.6M private placement to expand surgical robotics globally
Evidence notes
- SS Innovations disclosed an $18.6M private placement to support global sales of its SSI Mantra surgical robotic system.
- Proceeds are intended to support growth in India while preparing for market entry in the United States and European Union.
- The company had filed for FDA 510(k) clearance in December, with U.S. review expected to progress through 2026.
Company context
SS Innovations develops the SSi Mantra surgical robotic system, a modular multi-arm platform designed to make robotic surgery more accessible across specialties and markets.